Heart Transplantation Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, France, Japan - Size and Forecast 2024-2028

Published: Jan 2024

Pages: 172

SKU: IRTNTR40272

Snapshot

Heart Transplantation Therapeutics Market 2024-2028

The Heart Transplantation Therapeutics Market size is forecast to increase by USD 135.37 million, at a CAGR of 3.24% between 2023 and 2028.

The global heart transplantation therapeutics market has various novel and generic drugs that are available in different dosage forms. In addition, these dosage forms primarily comprise extended- and delayed-release tablets and capsules, dispersible granules for oral suspension, and powder for injection. Moreover, such multiple dosage forms of medicine are made available to improve adoption among patients, even if they contain large amounts of active pharmaceutical ingredients (APIs). Hence, such factors are positively impacting the market.

Technavio has segmented the market into Drug Class, Distribution Channel, and Geography

The drug class segment is classified into immunosuppressants, anti-infectives, analgesics, and others
The distribution channel segment is classified into hospital pharmacies, retail pharmacies, and online pharmacies
The geography segment includes key regions such as North America, Europe, Asia, and Rest of the World (ROW)

It also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historical data from 2018 - 2022, besides analyzing the current market scenario.

What will be the Size of the Heart Transplantation Therapeutics Market During the Forecast Period?

To learn more about this report, Download Report Sample

Heart Transplantation Therapeutics Market Segmentation by Drug Class, Distribution Channel and Geography Analysis

Drug Class Analysis

Immunosuppressants

The immunosuppressants segment is estimated to witness significant growth during the forecast period. Immunosuppressants segment can be referred to as drugs that are used to suppress the body's immune response. In addition, these drugs include immunosuppressive drugs and environmental toxins. Furthermore, immunosuppressants find their use in patients undergoing organ transplantation. If a new organ is donated by an identical twin, the recipient may not have to take these medications.

Get a glance at the market contribution of various segments Download PDF Sample

The immunosuppressants segment was the largest segment and was valued at USD 530.29 million in 2018. Moreover, when a patient undergoes organ transplantation, the new organ appears as a foreign agent in the body's defense system, which triggers a natural immune response against the entry of the transplanted organ. In addition, the body's defense system prepares the body to attack the transplanted organ and try to damage or destroy it. Therefore, immunosuppressants are used to offset this impact. Furthermore, these drugs suppress the body's ability to attack the newly transplanted organ and aid in keeping it healthy and free from damage. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Distribution Channel Analysis

Hospital pharmacies

Hospital pharmacies segment play a major role as a significant market segment within the global heart transplantation therapeutics market, acting as a crucial distribution channel for these specialized medications. In addition, one of the main reasons why hospital pharmacies distinguish themselves as a separate market segment is because they operate in close proximity to healthcare facilities and transplantation centers. Moreover, hospital pharmacies operate on the hospital's premises, which allows for efficient coordination among healthcare professionals involved with heart transplantation and the acquisition of critical therapeutics. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Retail pharmacies

The retail pharmacies segment is a vital link between drug companies and patients. In addition, they are often located in local communities and provide a convenient and easy-to-use point of access for patients looking to obtain prescription medications associated with heart transplantation therapies. Moreover, one of the biggest advantages of retail pharmacies within the global heart transplantation therapeutics market is their widespread presence. Furthermore, retail pharmacies are strategically located in both urban and suburban settings, ensuring that patients from all over the country have access to life-saving drugs. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The market growth in North America is fuelled by the sales of immunosuppressants and the increasing prevalence of various associated risk factors for heart transplantation in the region. In addition, the US was the largest revenue contributor to the market in the region. Moreover, the high market share of the US is attributed to the rising number of organ transplantation procedures, including heart transplantation, in the country and the availability of advanced healthcare infrastructure, which ensures the continuous supply of therapeutics to patients undergoing heart transplantation. In addition, the prevalence of cardiovascular diseases is also rising in the region. Hence, such factors are driving the market growth in North America during the forecast period.

Buy Full Report Now

Key Heart Transplantation Therapeutics Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

AbbVie Inc: The company offers heart transplantation therapeutics such as Gengraf which is used to help prevent organ rejection in people who have received heart transplants.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Heart Transplantation Therapeutics Market: Key Drivers, Trends, Challenges, and Customer Landscape

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.

Key Heart Transplantation Therapeutics Market Drivers

One of the key factors driving the heart transplantation therapeutics market growth is the high dependency on immunosuppressants for heart transplantation. Several advances have been made in surgical techniques across the world, especially in organ transplants. Therefore, such advances are increasing the demand for organ transplantations, including heart transplantation. Furthermore, graft rejection is one of the major challenges associated with organ transplantation, which is further intensified in heart transplantation.

Moreover, many research studies have proved that after the introduction of immunosuppressive drugs in the management of post-heart transplant patients, the incidence of rejection decreased significantly. In addition, this further results in the improvement in mortality and long-term outcomes. Furthermore, the immunosuppressants intended for maintenance regimens are used throughout the patient's life to prevent both acute and chronic rejection. Hence, such factors are driving the market growth during the forecast period.

Significant Heart Transplantation Therapeutics Market Trends

A key factor shaping the heart transplantation therapeutics market growth is the advent of techniques for heart transplantation. Organ transplantation is one of the foremost emerging fields in the modern medical therapy area and several patients across the world have undergone the transplantation of various organs. In addition, the transplantation of organs such as lungs, pancreas, and intestines is also occurring.

Moreover, revolutionary achievements in the field of regenerative therapies have generated interest among researchers, and they are discovering possible regenerative medicinal applications in organ transplantation, including heart transplantation. In addition, several novel technologies, including stem cells and tissue engineering, have proved to have the potential to enhance organ functions or repair damaged organs. Hence, such factors are driving the market growth during the forecast period.

Major Heart Transplantation Therapeutics Market Challenges

Adverse effects of immunosuppressants are one of the key challenges hindering the heart transplantation therapeutics market growth. The global heart transplantation therapeutics market has different immunosuppressants that are utilized for the prevention and treatment of the symptoms caused by heart transplantation. In addition, immunosuppressants are drugs that reduce the immune system's response in rejecting a transplanted organ.

Moreover, these drugs are highly effective in reducing the risk of organ rejection; however, they are associated with several side effects. In addition, even though the side effects of immunosuppressants are often mild, they last for a long time. Therefore, these side effects significantly impact patient adherence to the treatment using immunosuppressive drugs. Hence, such factors are hindering the market growth during the forecast period.

Buy Now Full Report

Key Heart Transplantation Therapeutics Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Heart Transplantation Therapeutics Market Customer Landscape

Segment Overview

The heart transplantation therapeutics market report forecasts market growth by revenue at global, regional & country levels and provides a market growth analysis of the latest market trends and analysis trends and growth opportunities from 2018 to 2028.

Drug Class Outlook
- Immunosuppressants
- Anti-infectives
- Analgesics
- Others
Distribution Channel Outlook
- Hospital pharmacies
- Retail pharmacies
- Online pharmacies
Geography Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of the World (ROW)
  - Australia
  - Argentina
  - Brazil

Heart Transplantation Therapeutics Market Scope
Report Coverage	Details
Page number	172
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 3.24%
Market Growth 2024-2028	USD 135.37 million
Market structure	Fragmented
YoY growth 2023-2024(%)	2.76
Regional analysis	North America, Europe, Asia, and the Rest of the World (ROW)
Performing market contribution	North America at 35%
Key countries	US, Germany, UK, France, and Japan
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	AbbVie Inc., Astellas Pharma Inc., Biocon Ltd., Dr Reddys Laboratories Ltd., Endo International Plc, GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Jubilant Pharmova Ltd., LEO Pharma AS, Lupin Ltd., McKesson Corp., Novartis AG, Pfizer Inc., RPG Enterprises, Strides Pharma Science Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., F. Hoffmann La Roche Ltd., and Panacea Biotec Ltd.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Heart Transplantation Therapeutics Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the heart transplantation therapeutics market between 2023 and 2028
Precise estimation of the heart transplantation therapeutics market size and its contribution to the market in focus on the parent market
Detailed market research and growth analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies position and classification
Accurate market forecast about upcoming market growth and trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
A thorough market growth and forecasting analysis of the market’s competitive landscape and detailed information about companies
Comprehensive market analysis and report of factors that will challenge the growth of heart transplantation therapeutics market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Drug Class
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global heart transplantation therapeutics market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global heart transplantation therapeutics market 2018 - 2022 ($ million)

4.2 Drug Class Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Drug Class Segment 2018 - 2022 ($ million)

4.3 Distribution Channel Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Drug Class

6.1 Market segments
- Exhibit 30: Chart on Drug Class - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Drug Class - Market share 2023-2028 (%)

6.2 Comparison by Drug Class
- Exhibit 32: Chart on Comparison by Drug Class
- Exhibit 33: Data Table on Comparison by Drug Class

6.3 Immunosuppressants - Market size and forecast 2023-2028
- Exhibit 34: Chart on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Immunosuppressants - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Immunosuppressants - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Immunosuppressants - Year-over-year growth 2023-2028 (%)

6.4 Anti-infectives - Market size and forecast 2023-2028
- Exhibit 38: Chart on Anti-infectives - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Anti-infectives - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Anti-infectives - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Anti-infectives - Year-over-year growth 2023-2028 (%)

6.5 Analgesics - Market size and forecast 2023-2028
- Exhibit 42: Chart on Analgesics - Market size and forecast 2023-2028 ($ million)
- Exhibit 43: Data Table on Analgesics - Market size and forecast 2023-2028 ($ million)
- Exhibit 44: Chart on Analgesics - Year-over-year growth 2023-2028 (%)
- Exhibit 45: Data Table on Analgesics - Year-over-year growth 2023-2028 (%)

6.6 Others - Market size and forecast 2023-2028
- Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ million)
- Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
- Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)

6.7 Market opportunity by Drug Class
- Exhibit 50: Market opportunity by Drug Class ($ million)
- Exhibit 51: Data Table on Market opportunity by Drug Class ($ million)

7 Market Segmentation by Distribution Channel

7.1 Market segments
- Exhibit 52: Chart on Distribution Channel - Market share 2023-2028 (%)
- Exhibit 53: Data Table on Distribution Channel - Market share 2023-2028 (%)

7.2 Comparison by Distribution Channel
- Exhibit 54: Chart on Comparison by Distribution Channel
- Exhibit 55: Data Table on Comparison by Distribution Channel

7.3 Hospital pharmacies - Market size and forecast 2023-2028
- Exhibit 56: Chart on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Hospital pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Hospital pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Hospital pharmacies - Year-over-year growth 2023-2028 (%)

7.4 Retail pharmacies - Market size and forecast 2023-2028
- Exhibit 60: Chart on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 61: Data Table on Retail pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 62: Chart on Retail pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 63: Data Table on Retail pharmacies - Year-over-year growth 2023-2028 (%)

7.5 Online pharmacies - Market size and forecast 2023-2028
- Exhibit 64: Chart on Online pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 65: Data Table on Online pharmacies - Market size and forecast 2023-2028 ($ million)
- Exhibit 66: Chart on Online pharmacies - Year-over-year growth 2023-2028 (%)
- Exhibit 67: Data Table on Online pharmacies - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by Distribution Channel
- Exhibit 68: Market opportunity by Distribution Channel ($ million)
- Exhibit 69: Data Table on Market opportunity by Distribution Channel ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 71: Chart on Market share by geography 2023-2028 (%)
- Exhibit 72: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 73: Chart on Geographic comparison
- Exhibit 74: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 75: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 91: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 UK - Market size and forecast 2023-2028
- Exhibit 99: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.10 Japan - Market size and forecast 2023-2028
- Exhibit 103: Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 104: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 105: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 106: Data Table on Japan - Year-over-year growth 2023-2028 (%)

9.11 France - Market size and forecast 2023-2028
- Exhibit 107: Chart on France - Market size and forecast 2023-2028 ($ million)
- Exhibit 108: Data Table on France - Market size and forecast 2023-2028 ($ million)
- Exhibit 109: Chart on France - Year-over-year growth 2023-2028 (%)
- Exhibit 110: Data Table on France - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 111: Market opportunity by geography ($ million)
- Exhibit 112: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 113: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 114: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 115: Overview on factors of disruption

11.4 Industry risks
- Exhibit 116: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 117: Vendors covered

12.2 Market positioning of vendors
- Exhibit 118: Matrix on vendor position and classification

12.3 AbbVie Inc.
- Exhibit 119: AbbVie Inc. - Overview
- Exhibit 120: AbbVie Inc. - Product / Service
- Exhibit 121: AbbVie Inc. - Key news
- Exhibit 122: AbbVie Inc. - Key offerings

12.4 Astellas Pharma Inc.
- Exhibit 123: Astellas Pharma Inc. - Overview
- Exhibit 124: Astellas Pharma Inc. - Product / Service
- Exhibit 125: Astellas Pharma Inc. - Key news
- Exhibit 126: Astellas Pharma Inc. - Key offerings

12.5 Biocon Ltd.
- Exhibit 127: Biocon Ltd. - Overview
- Exhibit 128: Biocon Ltd. - Business segments
- Exhibit 129: Biocon Ltd. - Key offerings
- Exhibit 130: Biocon Ltd. - Segment focus

12.6 Dr Reddys Laboratories Ltd.
- Exhibit 131: Dr Reddys Laboratories Ltd. - Overview
- Exhibit 132: Dr Reddys Laboratories Ltd. - Business segments
- Exhibit 133: Dr Reddys Laboratories Ltd. - Key offerings
- Exhibit 134: Dr Reddys Laboratories Ltd. - Segment focus

12.7 F. Hoffmann La Roche Ltd.
- Exhibit 135: F. Hoffmann La Roche Ltd. - Overview
- Exhibit 136: F. Hoffmann La Roche Ltd. - Business segments
- Exhibit 137: F. Hoffmann La Roche Ltd. - Key news
- Exhibit 138: F. Hoffmann La Roche Ltd. - Key offerings
- Exhibit 139: F. Hoffmann La Roche Ltd. - Segment focus

12.8 GlaxoSmithKline Plc
- Exhibit 140: GlaxoSmithKline Plc - Overview
- Exhibit 141: GlaxoSmithKline Plc - Business segments
- Exhibit 142: GlaxoSmithKline Plc - Key news
- Exhibit 143: GlaxoSmithKline Plc - Key offerings
- Exhibit 144: GlaxoSmithKline Plc - Segment focus

12.9 Glenmark Pharmaceuticals Ltd.
- Exhibit 145: Glenmark Pharmaceuticals Ltd. - Overview
- Exhibit 146: Glenmark Pharmaceuticals Ltd. - Product / Service
- Exhibit 147: Glenmark Pharmaceuticals Ltd. - Key offerings

12.10 Intas Pharmaceuticals Ltd.
- Exhibit 148: Intas Pharmaceuticals Ltd. - Overview
- Exhibit 149: Intas Pharmaceuticals Ltd. - Product / Service
- Exhibit 150: Intas Pharmaceuticals Ltd. - Key offerings

12.11 LEO Pharma AS
- Exhibit 151: LEO Pharma AS - Overview
- Exhibit 152: LEO Pharma AS - Business segments
- Exhibit 153: LEO Pharma AS - Key offerings
- Exhibit 154: LEO Pharma AS - Segment focus

12.12 Lupin Ltd.
- Exhibit 155: Lupin Ltd. - Overview
- Exhibit 156: Lupin Ltd. - Product / Service
- Exhibit 157: Lupin Ltd. - Key news
- Exhibit 158: Lupin Ltd. - Key offerings

12.13 Novartis AG
- Exhibit 159: Novartis AG - Overview
- Exhibit 160: Novartis AG - Business segments
- Exhibit 161: Novartis AG - Key offerings
- Exhibit 162: Novartis AG - Segment focus

12.14 Panacea Biotec Ltd.
- Exhibit 163: Panacea Biotec Ltd. - Overview
- Exhibit 164: Panacea Biotec Ltd. - Product / Service
- Exhibit 165: Panacea Biotec Ltd. - Key offerings

12.15 Pfizer Inc.
- Exhibit 166: Pfizer Inc. - Overview
- Exhibit 167: Pfizer Inc. - Product / Service
- Exhibit 168: Pfizer Inc. - Key news
- Exhibit 169: Pfizer Inc. - Key offerings

12.16 Sun Pharmaceutical Industries Ltd.
- Exhibit 170: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibit 171: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 172: Sun Pharmaceutical Industries Ltd. - Key offerings

12.17 Teva Pharmaceutical Industries Ltd.
- Exhibit 173: Teva Pharmaceutical Industries Ltd. - Overview
- Exhibit 174: Teva Pharmaceutical Industries Ltd. - Business segments
- Exhibit 175: Teva Pharmaceutical Industries Ltd. - Key news
- Exhibit 176: Teva Pharmaceutical Industries Ltd. - Key offerings
- Exhibit 177: Teva Pharmaceutical Industries Ltd. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 178: Inclusions checklist
- Exhibit 179: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 180: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 181: Research methodology
- Exhibit 182: Validation techniques employed for market sizing
- Exhibit 183: Information sources

13.5 List of abbreviations
- Exhibit 184: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

heart transplantation therapeutics market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis